BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bortoluzzi A, Salum GA, da Rosa ED, Chagas VS, Castro MAA, Manfro GG. DNA methylation in adolescents with anxiety disorder: a longitudinal study. Sci Rep 2018;8:13800. [PMID: 30218003 DOI: 10.1038/s41598-018-32090-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Morris AS, Ratliff EL, Cosgrove KT, Steinberg L. We Know Even More Things: A Decade Review of Parenting Research. J Res Adolesc 2021;31:870-88. [PMID: 34820951 DOI: 10.1111/jora.12641] [Reference Citation Analysis]
2 Cerveira de Baumont A, Hoffmann MS, Bortoluzzi A, Fries GR, Lavandoski P, Grun LK, Guimarães LSP, Guma FTCR, Salum GA, Barbé-Tuana FM, Manfro GG. Telomere length and epigenetic age acceleration in adolescents with anxiety disorders. Sci Rep 2021;11:7716. [PMID: 33833304 DOI: 10.1038/s41598-021-87045-w] [Reference Citation Analysis]
3 Peedicayil J. The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders. Neuropsychiatr Dis Treat 2020;16:597-606. [PMID: 32184601 DOI: 10.2147/NDT.S242040] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Alberca CD, Papale LA, Madrid A, Gianatiempo O, Cánepa ET, Alisch RS, Chertoff M. Perinatal protein malnutrition results in genome-wide disruptions of 5-hydroxymethylcytosine at regions that can be restored to control levels by an enriched environment. Epigenetics 2021;16:1085-101. [PMID: 33172347 DOI: 10.1080/15592294.2020.1841871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Carola V, Cimino S, Bussone S, Cerniglia L, Tambelli R. Children With Disruptive Mood Dysregulation Disorder and Psychopathological Risk in Their Mothers: The Function of Global DNA Methylation. Front Psychiatry 2021;12:593500. [PMID: 33584381 DOI: 10.3389/fpsyt.2021.593500] [Reference Citation Analysis]
6 Sartori SB, Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol Ther 2019;204:107402. [PMID: 31470029 DOI: 10.1016/j.pharmthera.2019.107402] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 14.7] [Reference Citation Analysis]